Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. clinical research study
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Videos

Refine by
Date

  • Older

Clinical Research Study Articles & Analysis

36 news found

CD Genomics Unveils A Pioneering Genomics Approach—Long Amplicon Analysis (LAA) Service

CD Genomics Unveils A Pioneering Genomics Approach—Long Amplicon Analysis (LAA) Service

Targeted Gene Analysis: Offering an economical and efficient solution for targeted gene analysis, LAA proves ideal for studying specific regions of interest in extensive population studies or clinical research. 4. ...

ByCD Genomics


Bayer driving innovation in radiology with new research across the portfolio presented at ECR

Bayer driving innovation in radiology with new research across the portfolio presented at ECR

The findings from this review offer a perspective for comparison between clinical validation studies and real-world performance, offering some confidence that data from clinical validation studies will translate to real-world settings. ...

ByBayer AG


How Great Clinical Trial Managers Stand Out From The Rest

How Great Clinical Trial Managers Stand Out From The Rest

The Clinical Operations study team looks to you for guidance and help fulfilling its responsibilities. ...

ByBrio Group


Combines mesenchymal stem-cell-based product, with Kurve’s intranasal drug delivery technology

Combines mesenchymal stem-cell-based product, with Kurve’s intranasal drug delivery technology

The results demonstrated over 50% tumor reduction in a murine glioblastoma model. The study was conducted by an independent pre-clinical research organization. ...

ByKurve Therapeutics, Inc.


Evolution of ePROM: Advancements, Concerns, and the Way Forward

Evolution of ePROM: Advancements, Concerns, and the Way Forward

Flexible and Compliant Patient Questionnaire A well-designed drag-and-drop custom ePROM form creation enables cohort studies, patient registries, and clinical studies to proceed faster and in a scalable way while keeping the clinical research sites, sponsors, and Clinical ...

ByJeeva Informatics Solutions Inc.


NCI and rutgers university open phase 1 clinical trials of t cell receptor therapy targeting KK-LC-1for multiple solid tumors

NCI and rutgers university open phase 1 clinical trials of t cell receptor therapy targeting KK-LC-1for multiple solid tumors

T-Cure licensed the commercial rights of the KK-LC-1 TCR-T therapy and entered into a Cooperative Research and Development Agreement (CRADA) with the NCI in 2020. The Company also initiated pre-clinical and clinical studies on KK-LC-1 TCR-T with Rutgers University in 2021. ...

ByT-Cure BioScience, Inc.


Alexandra Clyde appointed to Sequana Medical Board of Directors

Alexandra Clyde appointed to Sequana Medical Board of Directors

She is a member of the Duke Margolis Value-Based Payment and Innovative Technology Consortium, the Health Technology Assessment International (HTAi) Policy Forum, and the Advisory Board for the Center for the Evaluation of Value and Risk in Health (CEVR) at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center. She ...

BySequana Medical NV


AlloVir Reports Blinded, Preliminary, Phase 2 Data Supporting the Ongoing Study of Posoleucel, a Multi-Virus-Specific T Cell Therapy, for the Treatment of BK Viremia in Kidney Transplant Recipients

AlloVir Reports Blinded, Preliminary, Phase 2 Data Supporting the Ongoing Study of Posoleucel, a Multi-Virus-Specific T Cell Therapy, for the Treatment of BK Viremia in Kidney Transplant Recipients

We aim to move beyond hematopoietic cell transplant patients to also address solid organ transplant patients, who are at high risk of viral infections due to long-term immunosuppression,” said Richard Riese, MD, PhD, Senior Vice President, Clinical Research, AlloVir. “The ongoing study of posoleucel in kidney transplant patients has ...

ByKalaris


Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting

Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting

Data presentations include review of the VE303 Phase 2 CONSORTIUM study, in which VE303 was well tolerated and highly active at preventing Clostridioides difficile infection recurrence in subjects at high risk of recurrence Further CONSORTIUM study analysis shows that the VE303 high dose led to more robust colonization, which in turn correlated with prevention ...

ByVedanta Biosciences, Inc


Edinburgh Molecular Imaging and Mauna Kea Technologies Announce Clinical Molecular Imaging Collaboration

Edinburgh Molecular Imaging and Mauna Kea Technologies Announce Clinical Molecular Imaging Collaboration

Edinburgh Molecular Imaging Ltd (EM Imaging) and Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) today announced a clinical research collaboration to study the potential of combining EM Imaging’s in vivo optical imaging agents and Mauna Kea’s confocal laser endomicroscopy platform to diagnose cancer. The combination of novel ...

ByEdinburgh Molecular Imaging


Tetra Bio-Pharma Provides Update on Research Collaboration with the University of Montreal Hospital Research Centre for Inhaled CBD

Tetra Bio-Pharma Provides Update on Research Collaboration with the University of Montreal Hospital Research Centre for Inhaled CBD

The clinical trial has been authorized by Health Canada, who also recently approved an amendment to the research protocol to increase the dosage of the study drug up to 100 mg of CBD to be assessed in the study. ...

ByTetra Bio-Pharma


RepliCel Announces Material Patent Milestones

RepliCel Announces Material Patent Milestones

Planning for clinical research studies under Japan's Act for the Safety of Regenerative Medicines (ASRM) is underway. ...

ByRepliCel Life Sciences


Bayer extends clinical development program for finerenone with Phase III study in children and adolescents with chronic kidney disease

Bayer extends clinical development program for finerenone with Phase III study in children and adolescents with chronic kidney disease

Christian Rommel, Member of the Executive Committee of Bayer AG’s Pharmaceutical Division and Head of Research and Development. “The new FIONA study extends our clinical research for finerenone to children and adolescents with chronic kidney disease, where the unmet need is high for new treatments to delay disease ...

ByBayer AG


Araris Biotech AG Expands Scientific Advisory Board with Appointment of Dr. Jeff Sharman and Dr. Clive Stanway

Araris Biotech AG Expands Scientific Advisory Board with Appointment of Dr. Jeff Sharman and Dr. Clive Stanway

Jeff Sharman is a practicing hematologist/oncologist at the Willamette Valley Cancer Institute and Research Center in Eugene, Oregon. He serves as the medical director of hematology research for the US Oncology network where he has helped build one of the largest clinical research groups studying blood cancer. ...

ByAraris Biotech AG


RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team

RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team

After extensive clinical advisory participation, the RCS-01 the study synopsis has now been delivered to RepliCel’s Tokyo-based CRO (clinical research organization) and regulatory teams who have commenced preparation of all the necessary Japanese-language documentation to launch the clinical ...

ByRepliCel Life Sciences


The MALDI-Imaging Lipidomics Service Is Now Available Through Lipidomics Platform

The MALDI-Imaging Lipidomics Service Is Now Available Through Lipidomics Platform

As a division of Creative Proteomics, Lipidomics is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, biotechnology and pharmaceutical companies. The company has recently announced the fully-developed MALDI-Imaging Lipidomics Service to research the distribution of lipids in tissues. ...

ByCreative Proteomics


Coala Life in collaboration with Region Gävleborg, Sweden, to run the TITAN-DM study on 500 patients with diabetes

Coala Life in collaboration with Region Gävleborg, Sweden, to run the TITAN-DM study on 500 patients with diabetes

Stockholm, October 7, 2021: Coala Life, a leading company in cloud-based remote monitoring of heart and lung diseases, is now conducting a clinical observational study in collaboration with researchers at the Gävleborg Region, Uppsala University and Karolinska Institute to increase knowledge about the incidence of atrial fibrillation in ...

ByCoala Life Inc.


T-cure bioscience, inc. And atlas antibodies ab enter a collaboration agreement for the development, manufacture, and supply of CT83 (KK-LC-1) monoclonal antibodies

T-cure bioscience, inc. And atlas antibodies ab enter a collaboration agreement for the development, manufacture, and supply of CT83 (KK-LC-1) monoclonal antibodies

Patients with KK-LC-1 positive tumors may be eligible inclusion in clinical trials of a KK-LC-1 targeted T-Cell therapy. Under the terms of the agreement, Atlas Antibodies AB will provide all manufacturing and product supply for KK-LC-1 mAb for the companion diagnostic for clinical development. ...

ByT-Cure BioScience, Inc.


Oxford Brain Diagnostics establishes a research-based clinical MRI study in Japan to investigate how Cortical Disarray Measurement (CDM) analysis may support differential diagnosis and estimate disease severity in Dementia patients

Oxford Brain Diagnostics establishes a research-based clinical MRI study in Japan to investigate how Cortical Disarray Measurement (CDM) analysis may support differential diagnosis and estimate disease severity in Dementia patients

In Japan, clinical MRI scanners are available for the diagnosis and evaluation of dementia. ...

ByOxford Brain Diagnostics Ltd.


Neuros Medical Announces Completion of Enrollment in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain

Neuros Medical Announces Completion of Enrollment in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain

Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the completion of enrollment in its pivotal QUEST (High-FreQUEncy Nerve Block for PoST-Amputation Pain) study. QUEST is a 180-subject, randomized, double blinded, active sham controlled ...

ByNeuros Medical, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT